MHRA has just posted this Drug Safety Information with respect to Phenergan Elixir PL 04425/0630, 100ml packs. The labelling may “cause confusion to diabetic patients”. This relates to the technical distinction between hydrogenated glucose (which is not considered as sugar and therefore does not carry the risks
Read more →
The images above illustrate an important point about parallel import of medication. At first glance the Oxis Turbohaler on the left shows a strength of 9 microgram and on the other side of the same Turbohaler, the English label shows 12 microgram (picture on the right). It
Read more →We have just receive some indication from the manufacturers (Sanofi Aventis + Bristol-Myer Squibb ) that Clopidogrel-containing medicines and proton pump inhibitors (PPIs) ‘should be avoided unless absolutely necessary’. The preliminary studies indicate a cytochrome P450-type interaction. Clopidogrel is a pro-drug which is metabolised in the liver,
Read more →
The MHRA has just posted another Class 4 Alert relating to the patient information leaflet (PIL) of Timoptol-LA 0.25% w/v & 0.5% w/v Gel-Forming Eye Drops Solutions. The dose printed on the PIL is wrong. It states a dose of twice a day instead of the correct
Read more →
We have just been alerted to this packaging issue with Priadel 400mg Prolonged Release. The labelling on the rear panel of the cartons are wrong. On the side of the box where you place the dispensing label, you have Lithium Carbonate 200mg incorrectly printed on it. Please
Read more →
